Search results
Showing 1381 to 1395 of 2184 results for guidelines
Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March
Omalizumab for previously treated chronic spontaneous urticaria (TA339)
Evidence-based recommendations on omalizumab (Xolair) for treating severe chronic spontaneous urticaria in people of 12 and over.
with advancing age because of a woman's decreasing ovarian reserve. The guideline currently recommends a shorter period of expectant...
Any explanatory notes(if applicable) Why this is important The guideline committee noted the lack of evidence on the diagnosis of active...
families where child abuse or neglect has occurred. Our review for this guideline identified 1 small-scale US study of a web-based...
focal and generalised seizures since publication of the original NICE guideline on epilepsy in 2004 have not been evaluated as...
Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March
clinical practice and inform future updates of key recommendations in this guideline. Source guidance details Comes from guidance Stable...
Any explanatory notes(if applicable) Why this is important:- This guideline recommends offering genetic testing to people with a 10%...
Any explanatory notes(if applicable) Why it is important:- The Guideline Committee identified variation in organisational attitudes to,...
Any explanatory notes(if applicable) Why this is important:- This guideline has identified that women with endometriosis and their...
Pulmonary artery pressure technologies for remote monitoring of chronic heart failure (HTG769)
Evidence-based recommendation on the routine use of pulmonary artery pressure technologies for remote monitoring of chronic heart failure.
Evidence summaries: new medicines – Interim process statement (PMG1)
This interim process statement sets out to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs
Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March
Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March